Skip to content
OpenCapital
Get started

Recursion Pharmaceuticals, Inc. RXRX Segment Reporting Other Item Amount

Segment Reporting Other Item Amount at other companies

Century Communities logo
Century CommunitiesCCS
$22.22M+279%
EyePoint, Inc. logo
EyePoint, Inc. EYPT
$4.06M+16.7%
Essential Utilities logo
Essential UtilitiesWTRG
-$75K+74.4%
Equitable Holdings logo
Equitable HoldingsEQH
$371M-5.1%
Proto Labs logo
Proto LabsPRLB
$128.08M+5.2%
Oppenheimer Holdings logo
Oppenheimer HoldingsOPY
$176.1M+77.2%

Segments

By segment

See full
Reportable Segment$13.35M-41.8%

Other financials

Income statement

See full
Revenue$6.5M-56.1%
Gross profit-$6.0M+15.0%
Operating income-$128.5M+32.8%
Net income-$117.5M+42.0%
EPS (diluted)-$0.22+56.0%

Balance sheet

See full
Cash & equivalents$665.2M+30.6%
Total debt$88.6M-24.6%
Total equity$1.0B+9.7%
Total assets$1.3B+2.6%

Cash flow

See full
Operating cash flow-$81.1M+38.5%
CapEx$258.0K-85.9%
Free cash flow-$81.4M+39.2%

Valuation

See full
Market cap$1.71B-23.7%
Enterprise value$1.14B-39.8%
P/S25.8×-11.8×

Profitability

See full
Gross margin7.2%—
Operating margin-881.3%-66.8pp
Net margin-842.9%-92.4pp
FCF margin-490.7%-102pp

Returns & leverage

See full
Return on equity-57.2%-14.4pp
Debt / equity0.1×0.0×
Current ratio5.5×+1.4×